China Biologic Products Holdings, Inc. (CBPO) financial statements (2020 and earlier)

Company profile

Business Address 18TH FL, JIALONG INTERNATIONALBUILDING
BEIJING, 100125
State of Incorp.
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

6/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 18418381144130
Cash and cash equivalents 18414581144130
Short-term investments  38   
Restricted cash and investments   64  
Receivables 3425191711
Inventory, net of allowances, customer advances and progress billings 1561261018976
Inventory 1561261018976
Prepaid expense    8
Deposits current assets 110   
Prepaid expense and other current assets6
Deferred tax assets 43322
Other undisclosed current assets 1421115(2)
Total current assets: 393369280264222
Noncurrent Assets
Property, plant and equipment 132105807351
Long-term investments and receivables 5449181111
Long-term investments 119181111
Accounts and financing receivable, after allowance for credit loss 4340   
Intangible assets, net (including goodwill)    34
Intangible assets, net (excluding goodwill)    34
Deposits noncurrent assets   131415
Restricted cash and investments   40313
Other noncurrent assets 253 
Deferred tax assets, net 1    
Other undisclosed noncurrent assets 23241286
Total noncurrent assets: 21218216713989
TOTAL ASSETS: 605551447404311
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 14141397
Accounts payable 610543
Taxes payable 75845
Debt   84108
Due to related parties    74
Other undisclosed current liabilities 6057233828
Total current liabilities: 73721216348
Noncurrent Liabilities
Long-term debt and lease obligation   4030 
Long-term debt, excluding current maturities   4030 
Liabilities, other than long-term debt 10131939
Deferred revenue and credits 45333
Deferred tax liabilities, net   8(3)3
Other liabilities 78833
Other undisclosed noncurrent liabilities   (8)3(3)
Total noncurrent liabilities: 101351366
Total liabilities: 848517210054
Stockholders' equity
Stockholders' equity attributable to parent 462382212238195
Common stock 00000
Treasury stock, value (56)(56)(77)(30) 
Additional paid in capital 105105247262
Accumulated other comprehensive income (loss) (25)(0)202214
Retained earnings 438334245174119
Stockholders' equity attributable to noncontrolling interest 5985636662
Total stockholders' equity: 521467275304257
TOTAL LIABILITIES AND EQUITY: 605551447404311

Income statement (P&L) ($ in millions)

6/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues 341296243203185
Cost of revenue (124)(106)(80)(65)(59)
Gross profit: 217190163138126
Operating expenses (73)(57)(47)(52)(55)
Other operating income, net     1
Other undisclosed operating income (loss)   (5)13
Operating income: 1441331118774
Nonoperating income 1031257
Investment income, nonoperating 862645
Interest and debt expense (0)(2)(4)(1)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes   411
Income from continuing operations before equity method investments, income taxes: 1541331239281
Income (loss) from equity method investments 3(1)923
Other undisclosed income (loss) from continuing operations before income taxes (2)3  (3)
Income from continuing operations before income taxes: 1541351319581
Income tax expense (25)(21)(27)(16)(15)
Income before gain (loss) on sale of properties: 1291141057966
Other undisclosed net loss   (9)(2) 
Net income: 129114967766
Net loss attributable to noncontrolling interest (24)(25)(25)(22)(21)
Net income attributable to parent: 10589715545
Other undisclosed net loss available to common stockholders, basic (3)(2)(1)(0)(0)
Net income available to common stockholders, basic: 10287705445
Other undisclosed net loss available to common stockholders, diluted     (2)
Net income available to common stockholders, diluted: 10287705443

Comprehensive Income ($ in millions)

6/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income: 129114967766
Other undisclosed comprehensive income (loss) (31)(24)(2)92
Comprehensive income: 9790948668
Comprehensive income (loss), net of tax, attributable to noncontrolling interest (19)(21)(25)2421
Other undisclosed comprehensive loss, net of tax, attributable to parent    (48)(42)
Comprehensive income, net of tax, attributable to parent: 7869696247

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: